BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17572714)

  • 21. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
    Cheah PL; Ong CW; Crispin P
    Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
    Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
    Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
    Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
    Slavin MA; Grigg AP; Schwarer AP; Szer J; Spencer A; Sainani A; Thursky KA; Roberts AW
    Bone Marrow Transplant; 2007 Jul; 40(2):157-63. PubMed ID: 17468774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report.
    Kozlowska-Skrzypczak M; Bembnista E; Kubiak A; Matuszak P; Schneider A; Komarnicki M
    Transplant Proc; 2014 Oct; 46(8):2873-6. PubMed ID: 25380939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.
    Crassard N; Hadden H; Pondarré C; Hadden R; Galambrun C; Piens MA; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
    Transpl Infect Dis; 2008 Jun; 10(3):177-83. PubMed ID: 18331389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic treatment with mono-phenyl-tri-(N-methyl-4-pyridyl)-porphyrin for pathogen inactivation in cord blood stem cell products.
    Trannoy LL; van Hensbergen Y; Lagerberg JW; Brand A
    Transfusion; 2008 Dec; 48(12):2629-37. PubMed ID: 18764827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the clinical characteristics of parenteral nutrition recipients admitted for initial hematopoietic stem cell transplantation.
    Sheean PM; Braunschweig CA
    J Am Diet Assoc; 2007 Aug; 107(8):1398-403. PubMed ID: 17659908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation.
    Lövenich H; Schütt-Gerowitt H; Keulertz C; Waldschmidt D; Bethe U; Söhngen D; Cornely OA
    Bone Marrow Transplant; 2005 May; 35(10):997-1001. PubMed ID: 15806134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation.
    Ninan MJ; Flowers CR; Roback JD; Arellano ML; Waller EK
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):895-904. PubMed ID: 17640593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor cells in a patient with multiple myeloma and hemoglobin SC disease.
    Tormey CA; Snyder EL; Cooper DL
    Transfusion; 2008 Sep; 48(9):1930-3. PubMed ID: 18513256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for microbial contamination of peripheral blood stem cell products.
    Donmez A; Aydemir S; Arik B; Tunger A; Cilli F; Orman M; Tombuloglu M
    Transfusion; 2012 Apr; 52(4):777-81. PubMed ID: 21981571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of hematopoietic cell transplants using plasma-depleted cord blood products that are not red blood cell reduced.
    Chow R; Nademanee A; Rosenthal J; Karanes C; Jaing TH; Graham ML; Tsukahara E; Wang B; Gjertson D; Tan P; Forman S; Petz LD
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1346-57. PubMed ID: 17950921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.